North America Infectious Diagnostics Market Outlook to 2024

Published : Dec-2017

No. of Pages : 596

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 8
2 Introduction 13
2.1 What Is This Report About? 13
2.2 Infectious Diagnostics Market Segmentation 13
2.3 Definitions of Markets Covered in the Report 15
3 Infectious Diagnostics Market, North America 20
3.1 Infectious Diagnostics Market, North America, Revenue ($m), 2010-2024 20
3.2 Infectious Diagnostics Market, North America, Category Comparison by Revenue ($m), 2010-2024 22
3.3 Infectious Diagnostics Market, North America, Revenue ($m), 2010-2017 24
3.4 Infectious Diagnostics Market, North America, Revenue ($m), 2017-2024 27
3.5 Infectious Diagnostics Market, North America, Volume (Units), 2010-2024 30
3.6 Infectious Diagnostics Market, North America, Volume (Units), 2010-2017 32
3.7 Infectious Diagnostics Market, North America, Volume (Units), 2017-2024 35
3.8 Infectious Diagnostics Market, North America, Company Share by Revenue ($m), 2017 38
4 Infectious Diagnostics Market, Canada 40
4.1 Infectious Diagnostics Market, Canada, Revenue ($m), 2010-2017 40
4.2 Infectious Diagnostics Market, Canada, Revenue ($m), 2017-2024 43
4.3 Infectious Diagnostics Market, Canada, Volume (Units), 2010-2017 90
4.4 Infectious Diagnostics Market, Canada, Volume (Units), 2017-2024 93
4.5 Infectious Diagnostics Market, Canada, Average Price ($), 2010-2024 142
4.6 Infectious Diagnostics Market, Canada, Distribution Share by Revenue ($m), 150
4.7 Infectious Diagnostics Market, Canada, Company Share by Revenue ($m), 2017 151
5 Infectious Diagnostics Market, Mexico 153
5.1 Infectious Diagnostics Market, Mexico, Revenue ($m), 2010-2017 153
5.2 Infectious Diagnostics Market, Mexico, Revenue ($m), 2017-2024 156
5.3 Infectious Diagnostics Market, Mexico, Volume (Units), 2010-2017 203
5.4 Infectious Diagnostics Market, Mexico, Volume (Units), 2017-2024 206
5.5 Infectious Diagnostics Market, Mexico, Average Price ($), 2010-2024 255
5.6 Infectious Diagnostics Market, Mexico, Distribution Share by Revenue ($m), 2017 261
5.7 Infectious Diagnostics Market, Mexico, Company Share by Revenue ($m), 2017 262
6 Infectious Diagnostics Market, United States 264
6.1 Infectious Diagnostics Market, United States, Revenue ($m), 2010-2017 264
6.2 Infectious Diagnostics Market, United States, Revenue ($m), 2017-2024 267
6.3 Infectious Diagnostics Market, United States, Volume (Units), 2010-2017 314
6.4 Infectious Diagnostics Market, United States, Volume (Units), 2017-2024 317
6.5 Infectious Diagnostics Market, United States, Average Price ($), 2010-2024 366
6.6 Infectious Diagnostics Market, United States, Distribution Share by Revenue ($m), 2017 373
6.7 Infectious Diagnostics Market, United States, Company Share by Revenue ($m), 2017 374
7 Overview of Key Companies in North America Infectious Diagnostics Market 376
7.1 Abbott Laboratories 376
7.2 F. Hoffmann-La Roche Ltd 376
7.3 Hologic Inc 376
7.4 Qiagen NV 377
7.5 Siemens Healthcare GmbH 377
7.6 Alere Inc 377
7.7 Beckman Coulter Inc 377
7.8 Bio-Rad Laboratories Inc 378
7.9 Becton Dickinson and Co 378
7.10 Cepheid 378
7.11 DiaSorin S.p.A 378
7.12 bioMerieux SA 379
7.13 Thermo Fisher Scientific Inc 379
8 Infectious Diagnostics Market Pipeline Products 380
9 Recent Developments 392
9.1 Corporate Communications 392
9.2 Financial Announcements 419
9.3 Government and Public Interest 546
9.4 Legal And Regulatory 549
9.5 Other Significant Developments 555
9.6 Product News 566
9.7 Strategy And Business Planning 578
10 Appendix 580
10.1 Research Methodology 581
10.2 GlobalData Consulting 585
10.3 Contact Us 586
10.4 Disclaimer 586

1.1 List of Tables
Table 1: Infectious Diagnostics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2010-2024 31
Table 2: Infectious Diagnostics Market, North America, Category Comparison by Revenue ($m), USD Constant, 2010-2024 33
Table 3: Infectious Diagnostics Market, North America, Revenue ($m), Historic, USD Constant, 2010-2017 35
Table 4: Infectious Diagnostics Market, North America, Revenue ($m), Forecast, USD Constant, 2017-2024 38
Table 5: Infectious Diagnostics Market, North America, Volume (Units), 2010-2024 41
Table 6: Infectious Diagnostics Market, North America, Volume (Units), Historic, 2010-2017 43
Table 7: Infectious Diagnostics Market, North America, Volume (Units), Forecast, 2017-2024 46
Table 8: Infectious Diagnostics Market, North America, Company Share by Revenue ($m), USD Constant, 2017 49
Table 9: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 51
Table 10: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 54
Table 11: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 57
Table 12: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 59
Table 13: Hepatitis Test Kits Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 61
Table 14: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 63
Table 15: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 65
Table 16: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 67
Table 17: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 69
Table 18: Polymerase Chain Reaction (PCR) Systems Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 71
Table 19: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 73
Table 20: Retrovirus Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 75
Table 21: Treponema pallidum Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 77
Table 22: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 79
Table 23: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 81
Table 24: Hepatitis Test Kits Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 83
Table 25: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 85
Table 26: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 87
Table 27: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 89
Table 28: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 91
Table 29: Polymerase Chain Reaction (PCR) Systems Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 93
Table 30: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 95
Table 31: Retrovirus Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 97
Table 32: Treponema pallidum Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 99
Table 33: Infectious Diagnostics Market, Canada, Volume (Units), Historic, 2010-2017 101
Table 34: Infectious Diagnostics Market, Canada, Volume (Units), Forecast, 2017-2024 104
Table 35: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Volume (Units), Historic, 2010-2017 107
Table 36: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Volume (Units), Historic, 2010-2017 109
Table 37: Hepatitis Test Kits Market, Canada, Volume (Units), Historic, 2010-2017 111
Table 38: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Volume (Units), Historic, 2010-2017 113
Table 39: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Volume (Units), Historic, 2010-2017 115
Table 40: Infectious Diagnostics Rapid Tests & POC Market, Canada, Volume (Units), Historic, 2010-2017 117
Table 41: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Volume (Units), Historic, 2010-2017 119
Table 42: Polymerase Chain Reaction (PCR) Systems Market, Canada, Volume (Units), Historic, 2010-2017 121
Table 43: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Volume (Units), Historic, 2010-2017 123
Table 44: Retrovirus Tests Market, Canada, Volume (Units), Historic, 2010-2017 125
Table 45: Treponema pallidum Diagnostic Tests Market, Canada, Volume (Units), Historic, 2010-2017 127
Table 46: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Volume (Units), Forecast, 2017-2024 130
Table 47: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Volume (Units), Forecast, 2017-2024 132
Table 48: Hepatitis Test Kits Market, Canada, Volume (Units), Forecast, 2017-2024 134
Table 49: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Volume (Units), Forecast, 2017-2024 136
Table 50: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Volume (Units), Forecast, 2017-2024 138
Table 51: Infectious Diagnostics Rapid Tests & POC Market, Canada, Volume (Units), Forecast, 2017-2024 140
Table 52: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Volume (Units), Forecast, 2017-2024 142
Table 53: Polymerase Chain Reaction (PCR) Systems Market, Canada, Volume (Units), Forecast, 2017-2024 144
Table 54: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Volume (Units), Forecast, 2017-2024 146
Table 55: Retrovirus Tests Market, Canada, Volume (Units), Forecast, 2017-2024 148
Table 56: Treponema pallidum Diagnostic Tests Market, Canada, Volume (Units), Forecast, 2017-2024 150
Table 57: Infectious Diagnostics Market, Canada, Average Price ($) Historic, 2010-2017 152
Table 58: Infectious Diagnostics Market, Canada, Average Price ($), Forecast, 2017-2024 156
Table 59: Infectious Diagnostics Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2017 160
Table 60: Infectious Diagnostics Market, Canada, Company Share by Revenue ($m), USD Constant, 2017 162
Table 61: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 164
Table 62: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 167
Table 63: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 170
Table 64: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 172
Table 65: Hepatitis Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 174
Table 66: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 176
Table 67: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 178
Table 68: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 180
Table 69: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 182
Table 70: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 184
Table 71: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 186
Table 72: Retrovirus Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 188
Table 73: Treponema pallidum Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 190
Table 74: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 192
Table 75: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 194
Table 76: Hepatitis Test Kits Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 196
Table 77: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 198
Table 78: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 200
Table 79: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 202
Table 80: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 204
Table 81: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 206
Table 82: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 208
Table 83: Retrovirus Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 210
Table 84: Treponema pallidum Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 212
Table 85: Infectious Diagnostics Market, Mexico, Volume (Units), Historic, 2010-2017 214
Table 86: Infectious Diagnostics Market, Mexico, Volume (Units), Forecast, 2017-2024 217
Table 87: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Volume (Units), Historic, 2010-2017 220
Table 88: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Volume (Units), Historic, 2010-2017 222
Table 89: Hepatitis Test Kits Market, Mexico, Volume (Units), Historic, 2010-2017 224
Table 90: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Volume (Units), Historic, 2010-2017 226
Table 91: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Volume (Units), Historic, 2010-2017 228
Table 92: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 230
Table 93: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Volume (Units), Historic, 2010-2017 232
Table 94: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Volume (Units), Historic, 2010-2017 234
Table 95: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Volume (Units), Historic, 2010-2017 236
Table 96: Retrovirus Tests Market, Mexico, Volume (Units), Historic, 2010-2017 238
Table 97: Treponema pallidum Diagnostic Tests Market, Mexico, Volume (Units), Historic, 2010-2017 240
Table 98: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Volume (Units), Forecast, 2017-2024 243
Table 99: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 245
Table 100: Hepatitis Test Kits Market, Mexico, Volume (Units), Forecast, 2017-2024 247
Table 101: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 249
Table 102: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Volume (Units), Forecast, 2017-2024 251
Table 103: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 253
Table 104: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 255
Table 105: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Volume (Units), Forecast, 2017-2024 257
Table 106: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 259
Table 107: Retrovirus Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 261
Table 108: Treponema pallidum Diagnostic Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 263
Table 109: Infectious Diagnostics Market, Mexico, Average Price ($) Historic, 2010-2017 265
Table 110: Infectious Diagnostics Market, Mexico, Average Price ($), Forecast, 2017-2024 268
Table 111: Infectious Diagnostics Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2017 271
Table 112: Infectious Diagnostics Market, Mexico, Company Share by Revenue ($m), USD Constant, 2017 273
Table 113: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 275
Table 114: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 278
Table 115: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 281
Table 116: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 283
Table 117: Hepatitis Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 285
Table 118: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 287
Table 119: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 289
Table 120: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 291
Table 121: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 293
Table 122: Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 295
Table 123: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 297
Table 124: Retrovirus Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 299
Table 125: Treponema pallidum Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 301
Table 126: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 303
Table 127: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 305
Table 128: Hepatitis Test Kits Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 307
Table 129: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 309
Table 130: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 311
Table 131: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 313
Table 132: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 315
Table 133: Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 317
Table 134: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 319
Table 135: Retrovirus Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 321
Table 136: Treponema pallidum Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 323
Table 137: Infectious Diagnostics Market, United States, Volume (Units), Historic, 2010-2017 325
Table 138: Infectious Diagnostics Market, United States, Volume (Units), Forecast, 2017-2024 328
Table 139: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Volume (Units), Historic, 2010-2017 331
Table 140: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Volume (Units), Historic, 2010-2017 333
Table 141: Hepatitis Test Kits Market, United States, Volume (Units), Historic, 2010-2017 335
Table 142: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Volume (Units), Historic, 2010-2017 337
Table 143: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Volume (Units), Historic, 2010-2017 339
Table 144: Infectious Diagnostics Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 341
Table 145: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Volume (Units), Historic, 2010-2017 343
Table 146: Polymerase Chain Reaction (PCR) Systems Market, United States, Volume (Units), Historic, 2010-2017 345
Table 147: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Volume (Units), Historic, 2010-2017 347
Table 148: Retrovirus Tests Market, United States, Volume (Units), Historic, 2010-2017 349
Table 149: Treponema pallidum Diagnostic Tests Market, United States, Volume (Units), Historic, 2010-2017 351
Table 150: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Volume (Units), Forecast, 2017-2024 354
Table 151: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Volume (Units), Forecast, 2017-2024 356
Table 152: Hepatitis Test Kits Market, United States, Volume (Units), Forecast, 2017-2024 358
Table 153: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Volume (Units), Forecast, 2017-2024 360
Table 154: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Volume (Units), Forecast, 2017-2024 362
Table 155: Infectious Diagnostics Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 364
Table 156: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Volume (Units), Forecast, 2017-2024 366
Table 157: Polymerase Chain Reaction (PCR) Systems Market, United States, Volume (Units), Forecast, 2017-2024 368
Table 158: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Volume (Units), Forecast, 2017-2024 370
Table 159: Retrovirus Tests Market, United States, Volume (Units), Forecast, 2017-2024 372
Table 160: Treponema pallidum Diagnostic Tests Market, United States, Volume (Units), Forecast, 2017-2024 374
Table 161: Infectious Diagnostics Market, United States, Average Price ($) Historic, 2010-2017 376
Table 162: Infectious Diagnostics Market, United States, Average Price ($), Forecast, 2017-2024 380
Table 163: Infectious Diagnostics Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 383
Table 164: Infectious Diagnostics Market, United States, Company Share by Revenue ($m), USD Constant, 2017 385
Table 165: Infectious Diagnostics Market Pipeline Products 390
Table 166: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 593

1.2 List of Figures
Figure 1: Infectious Diagnostics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2010-2024 30
Figure 2: Infectious Diagnostics Market, North America, Category Comparison by Revenue ($m), USD Constant, 2010-2024 32
Figure 3: Infectious Diagnostics Market, North America, Revenue ($m), Historic, USD Constant, 2010-2017 34
Figure 4: Infectious Diagnostics Market, North America, Revenue ($m), Forecast, USD Constant, 2017-2024 37
Figure 5: Infectious Diagnostics Market, North America, Volume (Units), 2010-2024 40
Figure 6: Infectious Diagnostics Market, North America, Volume (Units), Historic, 2010-2017 42
Figure 7: Infectious Diagnostics Market, North America, Volume (Units), Forecast, 2017-2024 45
Figure 8: Infectious Diagnostics Market, North America, Company Share (%) 2017 48
Figure 9: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 50
Figure 10: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 53
Figure 11: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 56
Figure 12: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 58
Figure 13: Hepatitis Test Kits Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 60
Figure 14: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 62
Figure 15: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 64
Figure 16: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 66
Figure 17: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 68
Figure 18: Polymerase Chain Reaction (PCR) Systems Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 70
Figure 19: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 72
Figure 20: Retrovirus Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 74
Figure 21: Treponema pallidum Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 76
Figure 22: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 78
Figure 23: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 80
Figure 24: Hepatitis Test Kits Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 82
Figure 25: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 84
Figure 26: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 86
Figure 27: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 88
Figure 28: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 90
Figure 29: Polymerase Chain Reaction (PCR) Systems Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 92
Figure 30: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 94
Figure 31: Retrovirus Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 96
Figure 32: Treponema pallidum Diagnostic Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 98
Figure 33: Infectious Diagnostics Market, Canada, Volume (Units), Historic, 2010-2017 100
Figure 34: Infectious Diagnostics Market, Canada, Volume (Units), Forecast, 2017-2024 103
Figure 35: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Volume (Units), Historic, 2010-2017 106
Figure 36: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Volume (Units), Historic, 2010-2017 108
Figure 37: Hepatitis Test Kits Market, Canada, Volume (Units), Historic, 2010-2017 110
Figure 38: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Volume (Units), Historic, 2010-2017 112
Figure 39: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Volume (Units), Historic, 2010-2017 114
Figure 40: Infectious Diagnostics Rapid Tests & POC Market, Canada, Volume (Units), Historic, 2010-2017 116
Figure 41: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Volume (Units), Historic, 2010-2017 118
Figure 42: Polymerase Chain Reaction (PCR) Systems Market, Canada, Volume (Units), Historic, 2010-2017 120
Figure 43: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Volume (Units), Historic, 2010-2017 122
Figure 44: Retrovirus Tests Market, Canada, Volume (Units), Historic, 2010-2017 124
Figure 45: Treponema pallidum Diagnostic Tests Market, Canada, Volume (Units), Historic, 2010-2017 126
Figure 46: Chlamydia trichomatis Diagnostic Test Kits Market, Canada, Volume (Units), Forecast, 2017-2024 129
Figure 47: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Canada, Volume (Units), Forecast, 2017-2024 131
Figure 48: Hepatitis Test Kits Market, Canada, Volume (Units), Forecast, 2017-2024 133
Figure 49: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Canada, Volume (Units), Forecast, 2017-2024 135
Figure 50: Infectious Diagnostics Multiple Parameter Test Kits Market, Canada, Volume (Units), Forecast, 2017-2024 137
Figure 51: Infectious Diagnostics Rapid Tests & POC Market, Canada, Volume (Units), Forecast, 2017-2024 139
Figure 52: Mycobacterium tuberculosis Diagnostic Tests Market, Canada, Volume (Units), Forecast, 2017-2024 141
Figure 53: Polymerase Chain Reaction (PCR) Systems Market, Canada, Volume (Units), Forecast, 2017-2024 143
Figure 54: Post Streptococcus pyogenes Diagnostic Tests Market, Canada, Volume (Units), Forecast, 2017-2024 145
Figure 55: Retrovirus Tests Market, Canada, Volume (Units), Forecast, 2017-2024 147
Figure 56: Treponema pallidum Diagnostic Tests Market, Canada, Volume (Units), Forecast, 2017-2024 149
Figure 57: Infectious Diagnostics Market, Canada, Company Share (%) 2017 161
Figure 58: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 163
Figure 59: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 166
Figure 60: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 169
Figure 61: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 171
Figure 62: Hepatitis Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 173
Figure 63: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 175
Figure 64: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 177
Figure 65: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 179
Figure 66: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 181
Figure 67: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 183
Figure 68: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 185
Figure 69: Retrovirus Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 187
Figure 70: Treponema pallidum Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 189
Figure 71: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 191
Figure 72: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 193
Figure 73: Hepatitis Test Kits Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 195
Figure 74: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 197
Figure 75: Infectious Diagnostics Multiple Parameter Test Kits Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 199
Figure 76: Infectious Diagnostics Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 201
Figure 77: Mycobacterium tuberculosis Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 203
Figure 78: Polymerase Chain Reaction (PCR) Systems Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 205
Figure 79: Post Streptococcus pyogenes Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 207
Figure 80: Retrovirus Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 209
Figure 81: Treponema pallidum Diagnostic Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 211
Figure 82: Infectious Diagnostics Market, Mexico, Volume (Units), Historic, 2010-2017 213
Figure 83: Infectious Diagnostics Market, Mexico, Volume (Units), Forecast, 2017-2024 216
Figure 84: Chlamydia trichomatis Diagnostic Test Kits Market, Mexico, Volume (Units), Historic, 2010-2017 219
Figure 85: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Mexico, Volume (Units), Historic, 2010-2017 221
Figure 86: Hepatitis Test Kits Market, Mexico, Volume (Units), Historic, 2010-2017 223
Figure 87: Human Papilloma Virus

Filed in: In Vitro Diagnostic, Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026 “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period” The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain e......	$4950
Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact) Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area. The model discusses in detail the impact of COVID-19 on Assisted Reproductive Technology Devices market for the year 2020 and beyond. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat infertile women to achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are no......	$7500
Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic preg......	$7500
Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028 Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028 Summary Hemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively. Patients can be categorized as mild, moderate or severe depending on the percentage of circulating FVIII or FIX in their blood. Patients can be treated either on-demand or prophylactically using plasma-derived or recombinant replacement factors, the current standard of care. Although these therapies are effective, they are associated with a great treatment burden. There is a significant unmet need for new therapies that can reduce the great treatment burden associated with intravenous administration, the frequency of prophylactic infusions, and the risk of developing neutralizing a......	$10995
Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human Immunodeficiency Virus (HIV) has become one of the world's most serious health issues affecting approximately 36.9 million people. The epidemiology of HIV infections varies from one geographical region to another. Sources indicate that in many countries, incidence rates for HIV have stabilized due to the campaigns that provide condoms, pre-exposure prophylaxis, sterile needles, syringes, antiretroviral therapy (ART), and prevention of mother-to-child transmission interv......	$7500
Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia trachomatis. Patient access to Chlamydia screening, and thus the number of reported cases, varies substantially between countries. In some countries annual screening is recommended for specific patient groups deemed to be at higher risk of contracting the disease, such as sexually active females younger than 25 years. Additionally, screening of pregnant women for Chlamydia Trachomatis infections is currently recomme......	$7500
EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. There are two main types of lung cancer; small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC accounting for approximately 80-90% of all lung cancer cases. The 5-year survival rate for patients with stage IV disease is less than 5% as majority of patients present with the advanced or metastatic disease at diagnosis. EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating ......	$7500
Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cervical cancer screening has traditionally been based on cervical cytology. In recent years however, many countries have incorporated Human Papilloma Virus (HPV) tests into their cervical cancer and pre-cancer screening programs. Cytology based screening programs require a well-established healthcare infrastructure for processing and interpretation of samples. It is hoped that HPV screening methods may enable better prevention of these disease, these devices are also highly sensitive an......	$7500
Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model "Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cytomegalovirus (CMV) represents the most common congenital, viral infection in the developed world and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. Diagnosis of CMV infections is complex as symptoms are often non-specific and mimic mononucleosis or the flu. Approximately 21-25% of primary CMV infections are symptomatic ......	$7500
Human T-Lymphotropic Virus (HTLV) Test (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human T-Lymphotropic Virus (HTLV) Test (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human T-Lymphotropic Virus (HTLV) Test (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human T-Lymphotropic Virus (HTLV) is a retrovirus that infects T Lymphocyte cells. There are four strains of HTLV, out of these HTLV-I and HTLV-II are the most prevalent. HTLV-I is the causative agent of two severe neurological diseases. Specifically, sources indicate that up to 3-5% of patients infected with HTLV-I develop adult T-cell Leukemia/Lymphoma (ATLL) or HTLV-I-associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). Conversely, HTLV-II has been linked to elevate......	$7500

North America Infectious Diagnostics Market Outlook to 2024

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026

Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Human T-Lymphotropic Virus (HTLV) Test (In Vitro Diagnostics) – Global Market Analysis and Forecast Model